3Uchiyama K, Onishi H, Tani M, et al. Long-term prognosis after treatment of patients with choledocholithiasis [ J ]. Ann Surg, 2003,238( 1 ) :97-102.
4Rudllng M. Hepatic mRNA levels for the LDL receptor and HMG--COA reductase show coordinate regulation in vivo [ J]. J Lipid Res, 1992,33 (4) :493-501.
7Tazuma S.Gallstone disease:epidemiology,pathogenesis,and classifi-cation of biliary stones(common bile duct and intrahepatic)[J].Best Pract Res Clin Gastroenterol,2006,20(6):1075-1083.
8Timo Vuorela,Andrea Catte,Perttu S et al.Role of Lipids in Spheroi-dal High Density Lipoproteins[J].PLoS Computational Biology,2010,6(10):e1000964.
9Ohta T,Nagakawa T,Takeda t,et al.Histological evaluation of the in-trahepatic biliary tree in intrahepatic cholesterol stones,including im-munohistochemical staining against apolipoprotein A-1[J].Hepa-tology,1993,17(4):531-537.
10Indumathi Chennamsetty,Thierry Claudel et al.Farnesoid X receptorrepresses hepatic human APOA gene expression[J].The Journal ofClinical Investigation,2011,121(9):3724-3734.
